New Drug Approvals 2013 - Pt. XVIII - Obinutuzumab (Gazyva<sup>TM</sup>)
:quality(90)/ "Roche | Gazyva/Gazyvaro (obinutuzumab)")
Roche | Gazyva/Gazyvaro (obinutuzumab)
CLL/SLL: current perspectives across a range of potent agents - memoinOncology
AbbVie trials show sustained PFS of venetoclax therapy in CLL
Roche - Wikipedia
Frontiers | γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
Ibrutinib - Wikipedia
CLL/SLL: current perspectives across a range of potent agents - memoinOncology
Rituximab | Health and Medicine Wiki | Fandom
Mantle cell lymphoma: refining clinical outcomes beyond the current boundaries - memoinOncology
Obinutuzumab - wikidoc
British Journal of Haematology | Wiley Online Library
New Drug Approvals 2013 - Pt. XVIII - Obinutuzumab (Gazyva<sup>TM</sup>)
Optimizing timing, efficacy and tolerability in chronic lymphocytic leukemia - memoinOncology
Obinutuzumab - wikidoc
Follicular lymphoma: study results with bispecific antibodies and BTK inhibitors - memoinOncology
Phosphoinositide 3-kinase inhibitor - Wikipedia
British Journal of Haematology | Wiley Online Library
FDA accepts Genentech's sBLA for gazyva to treat untreated follicular lymphoma - Pharmaceutical Technology
CD20 - Wikipedia
Obinutuzumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Phosphoinositide 3-kinase inhibitor - Wikipedia
Roche - Wikipedia
How to pronounce Obinutuzumab | HowToPronounce.com
IMBRUVICA® (ibrutinib) - Cancer Therapy Advisor
Rituximab - Wikipedia
